Migraines

Intranasal Migraine Relief (One Year Study)

The purpose of this research study is to examine an investigational nasal spray for the treatment of an acute migraine headache. The study drug is a CGRP receptor blocker administered through a nasal spray. The study will last approximately one year long with 17 visits to our office.

Intranasal Migraine Relief

The purpose of this research study is to examine an investigational nasal spray for the treatment of one acute migraine headache.

Migraine Treatment Study

Migraines are a disease that cause disabling headaches. Baptist Health Center for Clinical Research is conducting a study to determine if the study drug is effective as a treatment of an ongoing or acute headache. The study drug is given in a single dose via infusion at our clinic.

*Compensation for time and travel may be available to those who qualify.